These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

591 related items for PubMed ID: 16928803

  • 21. Phosphodiesterase inhibitors.
    Boswell-Smith V, Spina D, Page CP.
    Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S252-7. PubMed ID: 16402111
    [Abstract] [Full Text] [Related]

  • 22. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.
    Schulze-Neick I, Hartenstein P, Li J, Stiller B, Nagdyman N, Hübler M, Butrous G, Petros A, Lange P, Redington AN.
    Circulation; 2003 Sep 09; 108 Suppl 1():II167-73. PubMed ID: 12970227
    [Abstract] [Full Text] [Related]

  • 23. Oral phosphodiesterase-5 inhibitors: effect of heme oxygenase inhibition on cGMP signalling in rat cavernous tissue.
    Abdel Aziz MT, Mostafa T, Atta H, Rashed L, Marzouk SA, Obaia EM, Sabry D, Hassouna AA, El-Shehaby AM, Abdel Aziz AT.
    Andrologia; 2007 Apr 09; 39(2):66-70. PubMed ID: 17430426
    [Abstract] [Full Text] [Related]

  • 24. Selective blockade of phosphodiesterase types 2, 5 and 9 results in cyclic 3'5' guanosine monophosphate accumulation in retinal pigment epithelium cells.
    Diederen RM, La Heij EC, Markerink-van Ittersum M, Kijlstra A, Hendrikse F, de Vente J.
    Br J Ophthalmol; 2007 Mar 09; 91(3):379-84. PubMed ID: 16943225
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Chronic administration of phosphodiesterase type 5 inhibitor suppresses renal production of endothelin-1 in dogs with congestive heart failure.
    Yamamoto T, Wada A, Ohnishi M, Tsutamoto T, Fujii M, Matsumoto T, Takayama T, Wang X, Kurokawa K, Kinoshita M.
    Clin Sci (Lond); 2002 Aug 09; 103 Suppl 48():258S-262S. PubMed ID: 12193099
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Rabbit corpus cavernosum smooth muscle shows a different phosphodiesterase profile than human corpus cavernosum.
    Qiu Y, Kraft P, Lombardi E, Clancy J.
    J Urol; 2000 Sep 09; 164(3 Pt 1):882-6. PubMed ID: 10953172
    [Abstract] [Full Text] [Related]

  • 31. Inhibitors of cyclic nucleotide phosphodiesterase 3 and 5 as therapeutic agents in heart failure.
    Stehlik J, Movsesian MA.
    Expert Opin Investig Drugs; 2006 Jul 09; 15(7):733-42. PubMed ID: 16787138
    [Abstract] [Full Text] [Related]

  • 32. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.
    Takimoto E, Champion HC, Li M, Belardi D, Ren S, Rodriguez ER, Bedja D, Gabrielson KL, Wang Y, Kass DA.
    Nat Med; 2005 Feb 09; 11(2):214-22. PubMed ID: 15665834
    [Abstract] [Full Text] [Related]

  • 33. Type V phosphodiesterase expression in cerebral arteries with vasospasm after subarachnoid hemorrhage in a canine model.
    Inoha S, Inamura T, Ikezaki K, Nakamizo A, Amano T, Fukui M.
    Neurol Res; 2002 Sep 09; 24(6):607-12. PubMed ID: 12238630
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of cGMP-specific phosphodiesterase type 5 reduces sodium excretion and arterial blood pressure in patients with NaCl retention and ascites.
    Thiesson HC, Jensen BL, Jespersen B, Schaffalitzky de Muckadell OB, Bistrup C, Walter S, Ottosen PD, Veje A, Skøtt O.
    Am J Physiol Renal Physiol; 2005 May 09; 288(5):F1044-52. PubMed ID: 15613622
    [Abstract] [Full Text] [Related]

  • 35. Inhibitors of phosphodiesterase 5 (PDE 5) inhibit the nerve-induced release of nitric oxide from the rabbit corpus cavernosum.
    Hallén K, Wiklund NP, Gustafsson LE.
    Br J Pharmacol; 2007 Feb 09; 150(3):353-60. PubMed ID: 17179943
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Phosphodiesterase 5 inhibitors and nitrergic transmission-from zaprinast to sildenafil.
    Gibson A.
    Eur J Pharmacol; 2001 Jan 05; 411(1-2):1-10. PubMed ID: 11137852
    [Abstract] [Full Text] [Related]

  • 39. Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction.
    Corbin JD, Francis SH, Webb DJ.
    Urology; 2002 Sep 05; 60(2 Suppl 2):4-11. PubMed ID: 12414329
    [Abstract] [Full Text] [Related]

  • 40. Stimulation of AQP2 membrane insertion in renal epithelial cells in vitro and in vivo by the cGMP phosphodiesterase inhibitor sildenafil citrate (Viagra).
    Bouley R, Pastor-Soler N, Cohen O, McLaughlin M, Breton S, Brown D.
    Am J Physiol Renal Physiol; 2005 Jun 05; 288(6):F1103-12. PubMed ID: 15644488
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.